- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/36 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class A61K 38/36
Total number of patents in this class: 1095
10-year publication summary
|
89
|
82
|
98
|
83
|
81
|
71
|
56
|
68
|
46
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2945 |
38 |
| Bioverativ Therapeutics Inc. | 213 |
26 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
25 |
| CSL Behring GmbH | 346 |
24 |
| The Children's Hospital of Philadelphia | 748 |
21 |
| Baxter International Inc. | 2452 |
16 |
| Baxter Healthcare S.A. | 1841 |
16 |
| RegenLab USA LLC | 70 |
16 |
| Ethicon, Inc. | 1244 |
13 |
| Omrix Biopharmaceuticals Ltd. | 155 |
13 |
| Quiapeg Pharmaceuticals AB | 47 |
12 |
| Octapharma AG | 204 |
11 |
| The Regents of the University of California | 19479 |
10 |
| Asahi Kasei Pharma Corporation | 139 |
10 |
| Fibrex Medical Research & Development GmbH | 11 |
10 |
| KM Biologics Co., Ltd | 90 |
10 |
| The Board of Trustees of the University of Illinois | 2665 |
9 |
| Mayo Foundation for Medical Education and Research | 3100 |
9 |
| Modernatx, Inc. | 1209 |
9 |
| Emory University | 1588 |
8 |
| Other owners | 789 |